Page last updated: 2024-08-23

elliptinium and Acquired Immune Deficiency Syndrome

elliptinium has been researched along with Acquired Immune Deficiency Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mathé, G1
Blanquet, D; Hage, F; Hallard, M; Mathe, G; Morette, C; Pontiggia, P1

Reviews

1 review(s) available for elliptinium and Acquired Immune Deficiency Syndrome

ArticleYear
Why have ten or so nontoxic, retrovirus integrase inhibitors not been made available for AIDS treatment? A ten-year experience [correction of experiment] must liberate them.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1999, Volume: 53, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Acriflavine; Cobalt; Ellipticines; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Vitamin B 12

1999

Other Studies

1 other study(ies) available for elliptinium and Acquired Immune Deficiency Syndrome

ArticleYear
Viral and immunologic follow up of 4 to 9 years of AIDS treatments by quadruple combinations of virostatics including integrase inhibitors applied in short sequences differing by drug rotation.
    Acta pharmacologica Sinica, 2002, Volume: 23, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Acriflavine; Adult; Anti-HIV Agents; Antiviral Agents; CD4-CD8 Ratio; Didanosine; Drug Therapy, Combination; Ellipticines; Female; Follow-Up Studies; HIV-1; Humans; Integrase Inhibitors; Male; Middle Aged; Protease Inhibitors; Stavudine; Vitamin B 12; Zalcitabine; Zidovudine

2002